Press Release 2012

Press Release 2012

Dr. Anurag Pande, Vice President, Scientific Affairs, Sabinsa Corporation, will be discussing Novel Actives from Developing Countries at the Sustainable Cosmetics Summit in New York, NY May 17-19, 2012.

Dr. Pande will share Sabinsa's experiences in developing novel actives from Asian countries, discussing:
- The importance finding new sources for active ingredients
- The biodiversity of Asian plants / botanicals
- Natural actives from Asian botanicals
- Challenges of sourcing actives from developing countries

The Sustainable Cosmetics Summit is a series of international summits that focuses on the leading issues the beauty industry faces concerning sustainability, natural, organic, fair trade and ecological products. The aim of the summit is to encourage sustainability in the beauty industry by bringing together key stakeholders and debate these major issues in a high-level forum.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.